Showing results (241-250 of 256) with videos related to
Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y C Tong, Jocelyn Mora, Asha C Bowen, et al.Pneumonia (Nathan Qld.)|November 24, 2024
Community versus academic hospital community-acquired pneumonia patients: a nested cohort studyJennifer L Y Tsang, Kian Rego, Alexandra Binnie, et al.Critical Care Medicine|May 24, 2022
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19Genevieve L Y Rocheleau, Terry Lee, Yassene Mohammed, et al.The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.Critical Care (London, England)|February 28, 2024
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumoniaChel Hee Lee, Mohammad M Banoei, Mariam Ansari, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled TrialKaren C Tran, Pierre Asfar, Matthew Cheng, et al.CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.Pageof 26